Blood calcium decreased and drugs of ingredients of mercaptopurine (a real world drug study)
Summary:
Blood calcium decreased is found among people who take drugs with ingredients of mercaptopurine, especially for people who are male, 50-59 old . This phase IV clinical study is created by eHealthMe based on reports of 27,036 people who have side effects when taking drugs with ingredients of mercaptopurine from the FDA, and is updated regularly.
Drug(s) considered in the study (i.e. both brand name and generic drugs): Mercaptopurine, Purinethol, Purixan.
27,036 people reported to have side effects when taking drugs with ingredients of mercaptopurine.
Among them, 16 people (0.06%) have Blood calcium decreased
What is Blood calcium decreased?
Blood calcium decreased is found to be associated with 1,169 drugs and 1,144 conditions by eHealthMe. Check the latest studies of Blood calcium decreased.
Number of reports submitted per year:

Gender of people who have Blood calcium decreased when taking drugs with ingredients of mercaptopurine *:
- female: 50 %
- male: 50 %
Age of people who have Blood calcium decreased when taking drugs with ingredients of mercaptopurine *:
- 0-1: 0.0 %
- 2-9: 0.0 %
- 10-19: 35.71 %
- 20-29: 0.0 %
- 30-39: 14.29 %
- 40-49: 0.0 %
- 50-59: 35.71 %
- 60+: 14.29 %
Conditions people have *:
You may use this to check any potential undetected conditions.
- Febrile Neutropenia (fever with reduced white blood cells): 6 people, 37.50%
- Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 5 people, 31.25%
- Leukaemia (blood or bone marrow cancer): 5 people, 31.25%
- Dermal Cyst: 5 people, 31.25%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 5 people, 31.25%
- Osteoporosis (bones weak and more likely to break): 1 person, 6.25%
- Indigestion: 1 person, 6.25%
Other drugs people take *:
You may use this to check any potential interacting drugs.
- Piperacillin And Tazobactam: 5 people, 31.25%
- Cyclophosphamide: 4 people, 25.00%
- Cytarabine: 3 people, 18.75%
- Imuran: 2 people, 12.50%
- Methotrexate: 2 people, 12.50%
- Vepesid: 2 people, 12.50%
- Augmentin '125': 2 people, 12.50%
- Iclusig: 2 people, 12.50%
- Fluconazole: 2 people, 12.50%
- Ethyol: 2 people, 12.50%
Other side effects people have besides Blood calcium decreased *:
You may use this to check any potential undetected side effects.
- White Blood Cell Count Decreased: 7 people, 43.75%
- Febrile Neutropenia (fever with reduced white blood cells): 6 people, 37.50%
- Neutrophil Count Decreased (less than normal number of neutrophil a type of blood cell): 6 people, 37.50%
- Photosensitivity Reaction: 5 people, 31.25%
- Gynecomastia (enlargement of the gland tissue of the male breast): 5 people, 31.25%
- Dermal Cyst: 5 people, 31.25%
- Hepatic Function Abnormal: 5 people, 31.25%
- Diarrhea: 4 people, 25.00%
- Blood Albumin Decreased: 4 people, 25.00%
- Protein Total Decreased: 3 people, 18.75%
* Approximation only. Some reports may have incomplete information.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Related studies
Drugs with ingredients of mercaptopurine, their effectiveness, alternatives and more:
How the study uses the data?
The study uses data from the FDA. It is based on mercaptopurine. All drugs that have the same active ingredients (e.g. brand name and generic drugs) are considered. Dosage of drugs is not considered in the study.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Cleocin cause Tumor? - 11 seconds ago
- Could Antara cause White Blood Cell Count Decreased? - 27 seconds ago
- Scoliosis and drugs of ingredients of abatacept - 30 seconds ago
- Vancomycin and Zometa drug interactions for men aged 60+ - 37 seconds ago
- Could Q10 cause Bruxism? - 40 seconds ago
- Biotin and Actinic Keratosis for Women aged 50-59 - 47 seconds ago
- Biotin and Solar Keratosis for Women aged 50-59 - 48 seconds ago
- Biotin and Keratosis - Actinic (Solar) for Women aged 50-59 - 48 seconds ago
- Biotin and Sun-Induced Skin Changes - Keratosis for Women aged 50-59 - 48 seconds ago
- Drug interactions of Sumatriptan Succinate and Olive Leaf - 49 seconds ago